Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
13203 | 789 | 39.8 | 57% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
2286 | 4159 | NONMEDICAL USE//PRESCRIPTION DRUG ABUSE//PRESCRIPTION OPIOIDS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | PRESCRIPTION STIMULANTS | Author keyword | 55 | 82% | 4% | 32 |
2 | NONMEDICAL USE | Author keyword | 42 | 71% | 4% | 34 |
3 | MORAL ENHANCEMENT | Author keyword | 41 | 87% | 3% | 20 |
4 | NONMEDICAL PRESCRIPTION DRUG USE | Author keyword | 35 | 89% | 2% | 16 |
5 | PRESCRIPTION DRUG MISUSE | Author keyword | 29 | 54% | 5% | 37 |
6 | COGNITIVE ENHANCEMENT | Author keyword | 22 | 32% | 7% | 58 |
7 | NEUROENHANCEMENT | Author keyword | 15 | 46% | 3% | 24 |
8 | NON MEDICAL USE OF PRESCRIPTION DRUGS | Author keyword | 12 | 86% | 1% | 6 |
9 | MORAL BIOENHANCEMENT | Author keyword | 11 | 100% | 1% | 6 |
10 | WOMEN GENDER | Address | 9 | 20% | 5% | 42 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ILLICIT USE | 246 | 78% | 21% | 164 |
2 | NONMEDICAL USE | 84 | 40% | 21% | 163 |
3 | PRESCRIPTION STIMULANTS | 56 | 50% | 10% | 81 |
4 | UNDERGRADUATE STUDENT SAMPLE | 19 | 76% | 2% | 13 |
5 | COSMETIC NEUROLOGY | 15 | 56% | 2% | 18 |
6 | PAIN MEDICATION | 15 | 73% | 1% | 11 |
7 | CONTROLLED MEDICATIONS | 14 | 100% | 1% | 7 |
8 | NONMEDICAL STIMULANT USE | 12 | 86% | 1% | 6 |
9 | NEUROENHANCEMENT | 10 | 73% | 1% | 8 |
10 | ENHANCING DRUGS | 9 | 50% | 2% | 13 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NEUROETHICS | 5 | 15% | 4% | 30 |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
A Systematic Review of Risk and Protective Factors Associated With Nonmedical Use of Prescription Drugs Among Youth in the United States: A Social Ecological Perspective | 2015 | 2 | 52 | 79% |
Nonmedical Use of Prescription Medications Among Adolescents in the United States: A Systematic Review | 2012 | 31 | 41 | 71% |
Misuse and diversion of stimulants prescribed for ADHD: A systematic review of the literature | 2008 | 209 | 42 | 40% |
What should we do about student use of cognitive enhancers? An analysis of current evidence | 2013 | 22 | 31 | 48% |
Should physicians prescribe cognitive enhancers to healthy individuals? | 2013 | 4 | 19 | 95% |
Pediatric neuroenhancement Ethical, legal, social, and neurodevelopmental implications | 2013 | 15 | 24 | 38% |
Modafinil and methylphenidate for neuroenhancement in healthy individuals: A systematic review | 2010 | 88 | 51 | 24% |
Neurocognitive enhancement: what can we do and what should we do? | 2004 | 185 | 14 | 43% |
Use of methylphenidate among medical students: a systematic review | 2013 | 2 | 5 | 100% |
Prescription Medication Sharing: A Systematic Review of the Literature | 2014 | 1 | 27 | 70% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | WOMEN GENDER | 9 | 20% | 5.3% | 42 |
2 | ABORAT 882 | 4 | 75% | 0.4% | 3 |
3 | OFF AE 340 | 2 | 67% | 0.3% | 2 |
4 | SOCIAL SCI MEDIA SPORTS | 2 | 67% | 0.3% | 2 |
5 | NEUROETH UNIT | 2 | 18% | 1.3% | 10 |
6 | ALCOHOL DRUG ABUSE TREATMENT PROGRAM | 2 | 13% | 1.4% | 11 |
7 | MED ETH PHILOSOPHY MED | 1 | 19% | 0.8% | 6 |
8 | ADM RECORDS PLICAT | 1 | 33% | 0.4% | 3 |
9 | INSERM 1061 | 1 | 40% | 0.3% | 2 |
10 | CYAHD | 1 | 33% | 0.3% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000177023 | CHRONIC NONCANCER PAIN//OPIOIDS//PRESCRIPTION MONITORING PROGRAMS |
2 | 0.0000135271 | MODAFINIL//ARMODAFINIL//INTEGRIS SLEEP DISORDERS OKLAHOMA |
3 | 0.0000131643 | RITALIN//METHYLPHENIDATE//METHYLPHENIDATE RITALIN |
4 | 0.0000112981 | CEIP MARSEILLE//CEIP//EVALUAT INFORMAT PHARMACODEPENDANCE ADDICTO |
5 | 0.0000095909 | NEUROETHICS//CEREBRAL SUBJECT//ORGANIZATIONAL NEUROSCIENCE |
6 | 0.0000081687 | HUMAN REPRODUCTIVE CLONING//GERM LINE THERAPY//HUMAN GENETIC ENGINEERING |
7 | 0.0000080012 | NON IDENTITY PROBLEM//POPULATION ETHICS//MERE ADDITION PARADOX |
8 | 0.0000067475 | ATTENTION DEFICIT HYPERACTIVITY DISORDER//METHYLPHENIDATE//ADHD |
9 | 0.0000062858 | ADULT ADHD//ADHD//JOURNAL OF ATTENTION DISORDERS |
10 | 0.0000054497 | SELF MEDICATION//MEDICINE USE//FKL |